A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid.
Amyloid beta (aβ) protein assembles into larger protein aggregates during the pathogenesis of Alzheimer's disease (AD) and there is increasing evidence that soluble aβ oligomers are a critical pathologic species. Diagnostic evaluations rely on the measurement of increased tau and decreased aβ42...
Guardado en:
Autores principales: | Adrianna Z Herskovits, Joseph J Locascio, Elaine R Peskind, Ge Li, Bradley T Hyman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c11db52ec3a644b586af0be0eb70ffb0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.
por: Richard J Perrin, et al.
Publicado: (2011) -
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: María-Salud García-Ayllón, et al.
Publicado: (2017) -
Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Giacomo Stroffolini, et al.
Publicado: (2021) -
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: Anna M. De Kort, et al.
Publicado: (2021) -
Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
por: Keisuke Takeda, et al.
Publicado: (2021)